Live financial news intelligence

Track market-moving stories before they get noisy

Real-time pulse of financial headlines curated from 5 premium feeds.

Latest market signal Czech Filtered by asset BF-A
Coverage 166,379 Raw stories ingested 21,863 rewritten in CS_CZ • 1 to rewrite (last 2 days).
Agents 7 Live Pipeline agents
  • FMP Stock News Fetch every minute 33s ago
  • FMP Forex News Fetch every 5 min 4m ago
  • CoinGecko News Fetch every 5 min 1m ago
  • FIO Stock News Fetch every 10 min 4m ago
  • Patria Stock News Fetch every 10 min 4m ago
  • Editorial rewrite Rewrite every minute running now
  • Asset sync Assets every 1 hour 23m ago

Latest coverage

Market News Feed

Scan headlines quickly, then expand any story for source context.

View
Language
Relevance
Clear
Details Date Content Source Relevance
2026-09-02 19:36 6d ago
2026-09-02 13:34 7d ago
Brown-Forman zveřejnila výsledky za 1. čtvrtletí fiskálního roku 2027
BF-A Brown-Forman Corporation
FMP Stock News 78
Original source text
Brown-Forman Corporation (BF.B) Q1 2027 Earnings Call September 2, 2026 10:00 AM EDT

Company Participants

Susanne Perram - VP & Director of Investor Relations
Lawson Whiting - CEO, President & Director
James Peters - Executive VP & CFO

Conference Call Participants

Drew Levine - JPMorgan Chase & Co, Research Division
Peter Grom - UBS Investment Bank, Research Division
Nadine Sarwat - Bernstein Institutional Services LLC, Research Division
Nik Modi - RBC Capital Markets, Research Division
Lauren Lieberman - Barclays Bank PLC, Research Division
William Kirk - ROTH Capital Partners, LLC, Research Division
Seamus Cassidy - TD Cowen, Research Division
Eric Serotta - Morgan Stanley, Research Division
Chris Pitcher - Rothschild & Co Redburn, Research Division
Gregory Porter - Evercore ISI Institutional Equities, Research Division

Presentation

Operator

Good day, and thank you for standing by. Welcome to the Brown-Forman Corporation First Quarter Fiscal Year 2027 Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded.

I would now like to hand the conference over to your speaker today, Sue Perram, Vice President, Director, Investor Relations. Ma'am, please go ahead.

Susanne Perram
VP & Director of Investor Relations

Thank you, and good morning, everyone. I would like to thank each of you for joining us today for Brown-Forman's First Quarter Fiscal Year 2027 Earnings Call. Joining me today are Lawson Whiting, President and Chief Executive Officer; and Jim Peters, Executive Vice President and Chief Financial Officer.

This morning's conference call contains forward-looking statements based on our current expectations. Numerous risks and uncertainties may cause actual results to differ materially from those anticipated or projected in these statements. Many of the factors that will determine future results are beyond the company's ability to control or predict. You should not place undue reliance on any forward-looking statements, and except as required by law, the company undertakes no obligation to update any of these statements, whether
2026-09-02 17:09 7d ago
2026-09-02 12:02 7d ago
Brown-Forman potvrdil celoroční výhled po výsledcích za 1. čtvrtletí
BF-A Brown-Forman Corporation
FMP Stock News 86
Original source text
Brown Forman NYSE: BF.A said its first-quarter fiscal 2027 results were largely in line with expectations, as growth from ready-to-drink products and Jack Daniel’s Tennessee Blackberry helped offset pressure in used barrel sales, tequila and several developed international markets.

President and Chief Executive Officer Lawson Whiting said innovation remains a key growth engine for the company amid selective consumer spending and continued softness in the broader spirits market. Brown-Forman reaffirmed its full-year outlook, including expectations for approximately flat organic net sales and a 3% to 5% decline in organic operating income.

Get Brown Forman alerts:

“Innovation is creating meaningful growth opportunities across our portfolio,” Whiting said, pointing to New Mix, the company’s RTD portfolio and Jack Daniel’s Tennessee Blackberry as major contributors during the quarter.

RTDs and Blackberry Support Sales New Mix delivered strong double-digit organic net sales growth in Mexico, where it has benefited from consumer interest in flavor, convenience and affordability. The product’s U.S. demand has exceeded Brown-Forman’s expectations since launch, according to Whiting, and the company is expanding into additional markets while adding flavors and package options.

New Mix is currently available in nine U.S. states, particularly areas with substantial Mexican American populations, Whiting said during the question-and-answer session. Despite its limited distribution, it has become the eighth-largest contributor to the RTD category in Nielsen data, he said.

Brown-Forman’s el Jimador Spritz also had a strong U.S. start. Based on recent Nielsen data, the company’s RTD portfolio contributed about one point of value growth to its overall U.S. performance.

Jack Daniel’s Tennessee Blackberry, meanwhile, contributed more than two points of U.S. value growth based on Nielsen takeaway trends. The flavor is now available in more than 30 international markets, with strong growth in Brazil, France and the United Arab Emirates. Brown-Forman is supporting the launch with broader distribution and additional pack sizes, while also extending the product into an RTD Jack Daniel’s Tennessee Blackberry & Lemonade offering.

Whiting said the Tennessee Blackberry rollout was designed as a two-year launch. The first year centered largely on the U.S. 750-milliliter format, while the current phase includes international expansion and additional U.S. sizes.

Barrel Sales, Tequila and International Markets Remain Pressured Growth initiatives were partly offset by a more than 60% decline in organic net sales for Brown-Forman’s non-branded and bulk business, primarily used barrel sales. Whiting said used barrel sales have fallen from more than $100 million two years ago to about $30 million, as demand from Scotch and Irish whiskey producers has remained below prior elevated levels.

The company expects used barrel sales to remain under pressure, though management expects the year-over-year dollar impact on net sales to moderate through the rest of fiscal 2027.

Brown-Forman’s full-strength tequila portfolio, including Herradura and el Jimador, posted a low-teens organic net sales decline. Whiting said the company is working to improve performance through marketing, clearer brand positioning and commercial execution.

Management cited improving U.S. takeaway trends for el Jimador, which has gained standing within the $15 to $30 tequila price range. Herradura faces a more difficult backdrop in higher-priced tequila segments, although Whiting said Brown-Forman plans to introduce new initiatives for the brand.

Emerging international markets generated 9% organic net sales growth, led by Mexico and the UAE. The UAE benefited from shipment timing, while Brazil faced a difficult comparison following prior-year supply chain disruptions and continued to run below last year despite recovering trends.

Developed international markets declined 8% organically. Australia grew 4%, helped by ordering patterns for Jack Daniel’s Tennessee Whiskey and RTD innovation, including the Australia-exclusive Jack Daniel’s Tennessee Serve whiskey-and-cola RTD. However, consumer demand remained weak across Germany, France and the U.K. In Canada, U.S.-produced spirits remained off shelves in most provinces, and Brown-Forman assumes the restrictions will continue for the rest of the fiscal year.

Profitability and Cash Flow Gross margin expanded 40 basis points to 60.2%, primarily due to lower costs related to timing and favorable portfolio changes. The improvement was partly offset by foreign exchange, including the stronger Mexican peso, and product mix pressure from fast-growing RTDs.

Chief Financial Officer Jim Peters said the first-quarter margin level could represent the high point for the year. The company expects higher-cost whiskey inventory produced during a period of elevated inflation to increasingly affect results, along with higher input costs and the impact of lower production volumes.

Organic advertising expense declined 4%, primarily due to timing, while organic selling, general and administrative expenses increased 5%, largely reflecting organizational changes aimed at reducing complexity and accelerating decision-making.

Reported operating income declined 3%. Organic operating income increased 4%. Earnings per share rose 6% to $0.38. Cash flow from operations increased $13 million to $173 million. Free cash flow increased $32 million to $161 million. The company repaid €300 million of 1.2% senior notes that matured July 7, 2026. Brown-Forman continues to expect fiscal 2027 capital expenditures of $60 million to $70 million and an effective tax rate of roughly 20% to 22%.

Leadership Transition and Outlook Whiting reiterated that he plans to retire after a successor is named, following nearly 30 years with Brown-Forman. The board’s Corporate Governance and Nominating Committee is considering internal and external candidates, and the company has not provided a timeline. Whiting expects to support the transition in an advisory capacity after a successor is appointed.

Management said it remains encouraged by U.S. trends, though Whiting characterized the improvement as gradual. The company expects depletions to exceed shipments for the full fiscal year as shipment timing benefits from the prior-year distributor transition and Tennessee Blackberry launch normalize.

“We feel good about our business,” Whiting said. “We feel more confident about our business today, and we’re going to continue to grow and do it on our own and create the most value that we can.”

About Brown Forman (NYSE:BF.A)Brown-Forman Corporation manufactures, bottles, imports, exports, markets, and sells various alcoholic beverages. It provides spirits, wines, whiskey spirits, whiskey-based flavored liqueurs, ready-to-drink and ready-to-pour products, ready-to-drink cocktails, vodkas, tequilas, champagnes, brandy, bourbons, and liqueurs. The company offers its products primarily under the Jack Daniel's, Woodford Reserve, Canadian Mist, GlenDronach, BenRiach, Glenglassaugh, Old Forester, Early Times, Slane Irish Whiskey, Coopers' Craft, el Jimador, Herradura, New Mix, Pepe Lopez, Antiguo, Finlandia, Korbel Champagne, and Sonoma-Cutrer brands.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Brown Forman Right Now?Before you consider Brown Forman, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Brown Forman wasn't on the list.

While Brown Forman currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
2026-08-31 10:34 9d ago
2026-08-26 11:01 14d ago
Brown-Forman B čeká růst zisku na akcii při nižších tržbách
BF-A Brown-Forman Corporation
FMP Stock News 72
Original source text
Brown-Forman B (BF.B - Free Report) is expected to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended July 2026. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.

The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on September 2. On the other hand, if they miss, the stock may move lower.

While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise.

Zacks Consensus EstimateThis company is expected to post quarterly earnings of $0.38 per share in its upcoming report, which represents a year-over-year change of +5.6%.

Revenues are expected to be $921.18 million, down 0.3% from the year-ago quarter.

Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 0.12% lower over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.

Investors should keep in mind that an aggregate change may not always reflect the direction of estimate revisions by each of the covering analysts.

Price, Consensus and EPS Surprise

Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. Our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction) -- has this insight at its core.

The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.

Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.

A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.

Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).

How Have the Numbers Shaped Up for Brown-Forman B?For Brown-Forman B, the Most Accurate Estimate is lower than the Zacks Consensus Estimate, suggesting that analysts have recently become bearish on the company's earnings prospects. This has resulted in an Earnings ESP of -1.09%.

On the other hand, the stock currently carries a Zacks Rank of #4.

So, this combination makes it difficult to conclusively predict that Brown-Forman B will beat the consensus EPS estimate.

Does Earnings Surprise History Hold Any Clue?Analysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.

For the last reported quarter, it was expected that Brown-Forman B would post earnings of $0.33 per share when it actually produced earnings of $0.12, delivering a surprise of -63.64%.

Over the last four quarters, the company has beaten consensus EPS estimates just once.

Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.

That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.

Brown-Forman B doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.

Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.
2026-08-10 15:10 30d ago
2026-08-10 09:45 30d ago
AbbVie a Becton Dickinson vedly, dividendy rostly všem
BF-A Brown-Forman Corporation
FMP Stock News 78
Original source text
About a year ago, 24/7 Wall St. flagged four overlooked Dividend Aristocrats as stealth growth plays, arguing that boring income names carried real upside if the market ever noticed. The scorecard is in, and it is split down the middle. Two of the four beat the market decisively, while the other two lagged. Below is a candid grading of the original quartet, plus three fresh Aristocrat-caliber income names where the setup looks compelling now.

Becton Dickinson: A Late Rally Salvages the Call Becton Dickinson (NYSE:BDX | BDX Price Prediction) was the toughest call of the original four, and it finally worked. Shares gained 25.5% in the past year and are up 17.47% year to date after a 9.1% one-week pop to $176.86.

The dividend engine still hums. Becton Dickinson pays a quarterly $1.05, with an annualized forward payout of $4.20, and the current yield is 2.4% against a forward P/E of 13. Coverage is not an issue: year-to-date free cash flow of $1.73 billion, up 44.6% year over year, comfortably funds the payout, and management raised FY26 adjusted EPS guidance to $12.62 to $12.72. The main risk is the tariff overhang and $450 million in non-cash impairment charges tied to strategic exits.

Grade: B+. A solid double for income holders who reinvested.

AbbVie: The Home Run of the Group AbbVie (NYSE:ABBV) was the star. Shares are up 47.4% over the trailing year and 16.7% year to date, closing at $246.04 on August 7. The immunology franchise did exactly what bulls hoped, with Skyrizi +24.4% and Rinvoq +24.5% more than offsetting Humira’s biosimilar-driven decline.

The dividend, currently $1.73 quarterly for an annualized forward $6.92, keeps grinding higher, and the yield stands at 2.8%. Safety metrics: free cash flow yield of 4.10%, interest coverage of 6.94x, and net debt/EBITDA of 2.26x. Q2 adjusted EPS of $3.65 beat the consensus estimate on $16.99 billion in revenue, +10.2% year over year. The trailing P/E of 69 reflects heavy amortization; the forward EPS guide of $13.87 to $14.07 normalizes the multiple considerably. Risk: continued Humira erosion and dilution from the $10.9 billion Apogee Therapeutics acquisition.

Grade: A. Nearly reached the aspirational analyst target.

Procter & Gamble: A Miss on Growth, Not on Income Procter & Gamble (NYSE:PG) was the disappointment of the group on price, down 9.2% from a year ago. However, shares finished at $145.79, up 4.0% year to date. Q4 FY26 revenue of $21.20 billion missed the $21.38 billion estimate, and the FY27 outlook of organic sales +1% to +3% with core EPS of $6.89 to $7.11 is workmanlike, not exciting.

For income buyers, however, this is still one of the safest checks in the market. The current quarterly payout is $1.0885, with an annualized forward payout of $4.354. Management just marked its 70th consecutive year of dividend increases and 136th consecutive year of dividend payments, cementing Dividend King status. FY26 free cash flow hit $15.835 billion, +12.74% year over year, and FY27 plans call for roughly $10 billion in dividends plus $5 billion in buybacks. Risks include a roughly $1 billion after-tax commodity and transport headwind in FY27.

Grade: C on price, A on income durability.

Brown-Forman: A Genuine Laggard Brown-Forman (NYSE:BF-A) was the clearest miss, −1.5% year on year, as spirits demand cooled in developed markets. Q4 FY26 GAAP EPS of $0.12 missed the $0.32 estimate after $132 million in non-cash brand impairments on Gin Mare and Diplomático.

The income case, however, is nearly untouchable. Brown-Forman logged its 82nd consecutive year of regular quarterly dividends and 42nd consecutive year of dividend increases, keeping it deep on the Aristocrat list. The Q4 FY26 payout of $0.2310 per share is well covered by FY26 free cash flow of $893 million, which was up 107% year over year. FY27 organic operating income was guided to −3% to −5%, and Citigroup bumped up its price target to $28 but kept a Neutral rating. The risks here are Jack Daniel’s volume softness and tariff exposure.

Grade: D on price, A on streak.

The New Picks Rounding out this update are three fresh Aristocrat-caliber names spanning cyclical, defensive, and industrial exposures. All three offer improving dividend coverage this fiscal year.

Albemarle: A Contrarian Aristocrat With Cyclical Torque Albemarle (NYSE:ALB) is the highest-conviction contrarian pick. The lithium producer has ripped 50.4% over the past year to $131.11, yet remains down 12.8% year to date and off 45.6% over five years. Q2 adjusted EPS of $3.75 beat by 15.72% on revenue of $1.74 billion (+31.1% year over year), with realized lithium prices recovering to $19.53/kg LCE from $12.17/kg.

Dividend safety is the debate. Free cash flow surged to $638 million in Q2, up 603% year over year, and cash stands at $1.63 billion against $10.28 billion of equity, with FY26 capex trimmed to roughly $500 million. That combination gives the payout runway even if lithium slips again. The bull case: operating leverage. Energy Storage revenue was +78% year over year at $1.28 billion with a 56.5% adjusted EBITDA margin. Risk: extreme lithium price sensitivity, plus operational hiccups including the Talison CGP3 fire and Kemerton Train 1 in care and maintenance.

Medtronic: The Clean Analyst Buy of the Bunch Medtronic (NYSE:MDT) offers the cleanest income setup here. Shares closed at $87.16, down 8.9% year to date but up 3.3% in the past month, with a low beta of 0.566. The current yield is 3.31%, backed by a $0.72 quarterly payout, an annualized forward $2.88. Management just marked its 49th consecutive year of dividend increases, one of the longest-running streaks in medical devices.

Coverage is the story. FY26 free cash flow was $5.426 billion (+4.65%) on $7.33 billion in operating cash flow, funding both the dividend and $1.035 billion in FY26 buybacks. FY27 guidance calls for organic revenue growth of 6.75% to 7.25% and non-GAAP EPS of $5.90 to $6.00. The CEO highlighted the “strongest annual top-line growth in 10 years.” Analysts are constructive, with a $98.44 mean price target. Risks include 230 basis points of Q4 operating-margin compression from tariffs and MiniMed separation costs.

Stanley Black & Decker: The Industrial Turnaround Stanley Black & Decker (NYSE:SWK) rounds out the list as the industrial turnaround. Shares are up 27.4% year to date and 35.1% over the past year, closing at $103.89. Q2 adjusted EPS of $1.57 beat $1.20 by 30.4%, and FY26 adjusted EPS guidance was lifted to $5.20 to $5.80.

The dividend just ticked higher, from $0.83 to $0.84 quarterly, taking the annualized forward to $3.36 at a yield of 3.2%. This is a well-documented multi-decade dividend grower. Coverage improved dramatically: Q2 free cash flow of $698.2 million, up 418%, and FY26 FCF guidance of $600 million to $800 million. Management also retired $1.7 billion of debt using CAM divestiture proceeds and repurchased $250 million in Q2. Analyst target stands at $96.91, so the easy money may be behind us, but the payout runway keeps widening. Note that roughly 250 basis points of Q2 gross margin came from a non-repeatable IEEPA tariff refund worth ~$0.17 in EPS.

The Takeaway The scorecard on the original four Aristocrats was two winners (AbbVie, Becton Dickinson), two laggards (Procter & Gamble, Brown-Forman) on price, though all four kept raising dividends on schedule. That is the point of owning Aristocrats: the income compounds regardless of what the multiple does in a given twelve months. Albemarle, Medtronic, and Stanley Black & Decker each offer a different flavor of the same trade, a cyclical rebound, a defensive compounder, and an industrial turnaround, with dividend coverage that has visibly improved this fiscal year.

Contact [email protected] for any questions or corrections.
2026-07-13 22:51 1mo ago
2026-07-13 16:39 1mo ago
Brown-Forman potvrdila odchod CEO a výhled 2027
BF-A Brown-Forman Corporation
FMP Stock News 78
Original source text
-

Board Initiates Search Process for Successor; Company Reiterates Fiscal 2027 Outlook

LOUISVILLE, Ky.--(BUSINESS WIRE)--Brown-Forman Corporation (NYSE: BFA, BFB) today announced Lawson Whiting has decided to retire from his role as President and Chief Executive Officer, effective upon the appointment of a successor. The Brown-Forman Board of Directors has initiated a search pursuant to its succession process that will consider internal and external candidates. The process will be led by the Corporate Governance and Nominating Committee, which is chaired by Tracy Skeans. Whiting will remain available to serve in an advisory capacity for a period of time following the appointment of a successor to ensure business continuity and support a smooth handover.

“On behalf of the Board and the Brown family, I want to thank Lawson for his nearly 30 years of dedication to Brown-Forman,” said Marshall B. Farrer, Chairman of Brown-Forman. “Lawson has been a steadfast steward of founder George Garvin Brown’s vision – leading this company through an era of macro challenges and change with a clear and consistent vision for building the most premium portfolio in the industry and ensuring there was ‘Nothing Better in the Market.’ Under Lawson’s leadership, Jack Daniel's extended its presence into new international markets and categories, Woodford Reserve grew into the world’s leading super-premium American whiskey, and our founding brand, Old Forester, tripled in volume and increased net sales six-fold over the last decade. Today, Brown-Forman’s portfolio is one of the most respected in the global spirits industry. The Board is deeply grateful for his leadership and his commitment to the people and brands of Brown-Forman.”

Farrer added, “We appreciate Lawson giving us ample notice of his decision to retire, as it allows the Board the opportunity to conduct a robust review of both internal and external talent. As we begin our search pursuant to our succession process, we do so with confidence in our business, our people, and our opportunities to create long-term value for all Brown-Forman stakeholders. Lawson will continue to advance our strategic and operational priorities, including expanding our geographic footprint, building brands that resonate with consumers, and enhancing operational efficiency, while the Board conducts the succession process.”

“It has been the privilege of a lifetime to lead Brown-Forman,” said Lawson Whiting, President and Chief Executive Officer of Brown-Forman. “From my earliest days with the company to my time as CEO, my tenure has been defined by the extraordinary people I have worked alongside. We are entering this transition from a position of strength. Brown-Forman has principled leadership, a foundation of iconic brands, and a global team with immense depth and talent. I have every confidence that the succession process will surface the right leader for Brown-Forman’s next generation of growth, and I look forward to supporting a seamless handoff that ensures our momentum never wavers.”

Wolf Pen Branch, which represents a controlling interest in Brown-Forman said, “We appreciate Lawson’s leadership and three decades of dedicated service to Brown-Forman. We are confident in the competitive position and financial strength of the business and in the Board's process underway to identify the next CEO to capitalize on growth opportunities for Brown-Forman.”

Brown-Forman also reiterated today its fiscal 2027 outlook as disclosed on June 4, 2026.

About Brown-Forman Corporation:

Brown-Forman Corporation is a global leader in the spirits industry, responsibly building exceptional beverage alcohol brands for more than 155 years. Headquartered in Louisville, Kentucky, we are guided by our founding promise, “Nothing Better in the Market.” Our premium portfolio includes the Jack Daniel’s Family of Brands, Woodford Reserve, Old Forester, New Mix, el Jimador, Herradura, The Glendronach, Glenglassaugh, Benriach, Diplomático Rum, Gin Mare, Fords Gin, Chambord, and Slane. With approximately 4,900 employees worldwide, we proudly share our passion for fine-quality spirits in more than 170 countries. Learn more at brown-forman.com and stay connected with us on LinkedIn, Instagram, and X.

Forward Looking Statements:

This press release contains statements, estimates, and projections that are “forward-looking statements” as defined under U.S. federal securities laws. Words such as “aim,” “ambition,” “anticipate,” “aspire,” “believe,” “can,” “continue,” “could,” “envision,” “estimate,” “expect,” “expectation,” “intend,” “may,” “might,” “plan,” “potential,” “project,” “pursue,” “see,” “seek,” “should,” “will,” “would,” and similar words indicate forward-looking statements, which speak only as of the date we make them. Except as required by law, we do not intend to update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise. By their nature, forward-looking statements involve risks, uncertainties, and other factors (many beyond our control) that could cause our actual results to differ materially from those expressed in or implied by the forward-looking statements. These risks and uncertainties include, but are not limited to:

Our substantial dependence upon the continued growth of the Jack Daniel’s family of brands Substantial competition from new entrants, consolidations by competitors and retailers, and other competitive activities, such as pricing actions (including price reductions, promotions, discounting, couponing, or free goods), marketing, category expansion, product introductions, or entry or expansion in our geographic markets or distribution networks Disruption of our distribution network or inventory fluctuations in our products by distributors, wholesalers, or retailers Risks from changes to the trade policies, tariffs, and import and export regulations of the United States or foreign governments and the effectiveness of our actions to mitigate the negative impact on our margins, sales, and/or distributors Changes in consumer preferences, consumption, or purchase patterns – particularly away from larger producers in favor of small distilleries or local producers, or away from brown spirits, our premium products, or spirits generally, and our ability to anticipate or react to them; further legalization of marijuana; bar, restaurant, travel, or other on-premise declines; shifts in demographic or health and wellness trends; or unfavorable consumer reaction to new products, line extensions, package changes, product reformulations, or other product innovation Route-to-consumer changes that affect the timing of our sales, temporarily disrupt the marketing or sale of our products, or result in higher fixed costs Production facility, aging warehouse, or supply chain disruption Imprecision in supply/demand forecasting Higher costs, lower quality, or unavailability of energy, water, raw materials, product ingredients, or labor Risks associated with acquisitions, dispositions, business partnerships, or investments – such as acquisition integration, termination difficulties or costs, or impairment in recorded value Unfavorable global or regional economic conditions and related economic slowdowns or recessions, low consumer confidence, high unemployment, weak credit or capital markets, budget deficits, burdensome government debt, austerity measures, higher interest rates, higher taxes, political instability, higher inflation, deflation, lower returns on pension assets, or lower discount rates for pension obligations Negative publicity related to our company, products, brands, marketing, executive leadership, employees, Board of Directors, family stockholders, operations, business performance, or prospects or risks relating to the increased risk of social media Product recalls or other product liability claims, product tampering, contamination, or quality issues Failure to attract or retain key executive or employee talent Impact of health epidemics and pandemics, and the risk of the resulting negative economic impacts and related governmental actions Risks associated with being a U.S.-based company with a global business, including commercial, political, and financial risks; local labor policies and conditions; compliance with local trade practices and other regulations; terrorism, kidnapping, extortion, or other types of violence; and health pandemics Failure to comply with anti-corruption laws, trade sanctions and restrictions, or similar laws or regulations Fluctuations in foreign currency exchange rates, particularly due to a stronger U.S. dollar A downgrade or potential downgrade of our credit ratings Changes in laws, regulatory measures, or governmental policies, especially those affecting production, importation, marketing, labeling, pricing, distribution, sale, or consumption of our beverage alcohol products Tax rate changes (including excise, corporate, sales or value-added taxes, property taxes, payroll taxes, import and export duties, and tariffs) or changes in related reserves, changes in tax rules or accounting standards, and the unpredictability and suddenness with which they can occur Decline in the social acceptability of beverage alcohol in significant markets Significant additional labeling or warning requirements or limitations on availability of our beverage alcohol products Counterfeiting and inadequate protection of our intellectual property rights Significant legal disputes and proceedings, or government investigations Cyberbreach or failure or corruption of our key information technology systems or those of our suppliers, customers, or direct and indirect business partners, or failure to comply with personal data protection laws Our status as a family “controlled company” under New York Stock Exchange rules, and our dual-class share structure For further information on these and other risks, please refer to our public filings, including the “Risk Factors” section of our Annual Report on Form 10-K and Quarterly Reports on Form 10-Q filed with the Securities and Exchange Commission.

More News From Brown-Forman Corporation

Back to Newsroom